Home  - Health_Conditions - Systemic Lupus Erythematosus

Books Baby Camera Phones Computers Games DVD Electronics Kitchen Magazines Music Garden Software Tools Toys Video Apparel & Accessories Jewelry & Watches Musical Instruments Health & Personal Care Beauty Sports & Outdoors Office Products

e99.com Bookstore

Images

Newsgroups

81-100 of 104    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Systemic Lupus Erythematosus:     more books (101)

Adding prasterone appears beneficial in lupus. (Disease Activity, Bone Density).(systemic lupus erythematosus ): An article from: Family Practice News by Nancy Walsh, 2003-05-01 Intestinal pseudo-obstruction as a presenting manifestation of systemic lupus erythematosus: case report and review of the literature.(Case Report): An article from: Southern Medical Journal by Hien, Nguyen, Niharika Khanna, 2004-02-01 Myelitis mistaken for bladder infection in SLE.(systemic lupus erythematosus)(RHEUMATOLOGY): An article from: Internal Medicine News by M. Alexander Otto, 2010-08-01 Systemic Lupus Erythematosus: An entry from Gale's <i>Gale Encyclopedia of Medicine, 3rd ed.</i> by Rosalyn, MD Carson-DeWitt, 2006 Eosinophilic enteritis with systemic lupus erythematosus.(Case Report): An article from: Southern Medical Journal by Prashanth R. Sunkureddi, Nguyen Luu, et all 2005-10-01 SYSTEMIC LUPUS ERYTHEMATOSUS by DANIEL L LARSON, 1961-01-01 Systemic lupus erythematosus: An entry from Thomson Gale's <i>Gale Encyclopedia of Alternative Medicine</i> by Belinda Rowland, 2001 Vitamin D repletion in SLE requires 2,000 IU.(Systemic lupus erythematosus)(RHEUMATOLOGY): An article from: Internal Medicine News by M. Alexander Otto, 2010-08-01 Systemic Lupus Erythematosus (Bailliere's Clinical Rheumatology) Lupus Erythematosus :A Review of the current Status of Discoid and Systemic Lupus Erythematosus and Their Variants by Edmund L. Dubois, 1966 Managing organ-threatening systemic lupus erythematosus.(Best practice): An article from: MedSurg Nursing by Richard L., Jr. Pullen, Jan D. Cannon, et all 2003-12-01 Lupus Erythematosus: a Review of the Current Status of Discoid and Systemic Lupus Erythematosus and Their Variants by edmund dubois, 1974-01-01 Stem cell transplantation may improve refractory SLE.(News)(systemic lupus erythematosus): An article from: Internal Medicine News by Mitchel L. Zoler, 2005-04-15 Stem cell transplant therapy improves refractory SLE.(Clinical Rounds)(systemic lupus erythematosus): An article from: Skin & Allergy News by Mitchel L. Zoler, 2005-05-01

lists with details

81. Clinical Trial: Study Of Systemic Lupus Erythematosus
    Study of systemic lupus erythematosus. This study is currently recruiting patients. Sponsored by. Condition. Lupus Nephritis systemic lupus erythematosus.  
    http://www.clinicaltrials.gov/ct/show/NCT00001372?order=1

82. Clinical Trial: Ultraviolet Light Therapy For Systemic Lupus Erythematosus
    Ultraviolet Light Therapy for systemic lupus erythematosus. systemic lupus erythematosus, Procedure ultraviolet A1 light treatment, Phase II.  
    http://www.clinicaltrials.gov/ct/show/NCT00004375?order=3

83. SYSTEMIC LUPUS ERYTHEMATOSUS - SLE - Lupus Erythematosus Society Of Saskatchewan
    systemic lupus erythematosus. is a voluntary association which is concerned about those people who are affected by systemic lupus erythematosus.  
    http://www.gpfn.sk.ca/health/support/less/lupusbro.html
    
    Extractions: Systemic lupus erythematosus (SLE) is a chronic inflammatory disease which may affect many different organs and tissues in the body. Women of child bearing age are typically affected, but individuals of any age, sex, or race may develop the disease. SLE while uncommon, is not rare, with an estimated disease prevalence of 1 in every 2,000 population. It is a condition which appears to be increasing in prominence especially over the last 15 to 20 years. This is likely explained by the earlier recognition of milder cases because of increased patient and physician awareness and by the enhanced availability of sensitive laboratory tests helpful in the diagnosis. Although the exact cause is not known, most of the features of the disease seem to be due to a fundamental abnormality of the body's immune system. The immune system is the body's defence mechanism against foreign substances entering the body. It depends on the formation of compounds called antibodies and on hite cells called lymphocytes which rise to the defense of the body in case of invasion by foreign agents such as germs or viruses. This is a normal and desirable process in the healthy individual.

84. Systemic Lupus Erythematosus (SLE)
    systemic lupus erythematosus (SLE). systemic lupus erythematosus (SLE) is a syndrome encompassing a spectrum of diseases defined by clinical criteria.  
    http://www.smbs.buffalo.edu/med/wnysadrc/systemic.htm
    
    Extractions: Systemic lupus erythematosus (SLE) is a syndrome encompassing a spectrum of diseases defined by clinical criteria. To have SLE, a patient must have at least four of the following: 1) malar rash, 2) discoid rash, 3) photosensitivity, 4) oral ulcers, 5) arthritis, 6) serositis (pleuritis or pericarditis), 7) renal disorder, 8) neurologic disorder, 9) hematologic disorder, 10) immunologic disorder (anti-dsDNA, anti-Sm, false positive VDRL or anti-phospholipid antibody), and 11) anti-nuclear antibody (ANA) . Some patients have only photosensitive skin rash, joint pains and oral ulcers, while others have systemic vasculitis involving the skin, lungs, bowel, kidneys and central nervous system . Serologic evidence of reactivity to antigens found in the nucleosome is common, including DNA, histones and various ribonucleoproteins . Reactivity to a large number of additional autoantigens, such as b 2 glycoprotein 1, CD45 and platelet factor 4, can be found in individual patients . Both cell mediated and humoral autoreactivity participate in human SLE . Many studies investigating SLE are hindered by a failure to isolate different patient subgroups, and study each in isolation. SLE encompasses so many different diseases, that very few features are common among all of them. A treatment or diagnostic test that is valid in one form may not be valid in another. Analyzing, for example, a drug in the treatment of SLE may reveal no significant benefit across the entire SLE population. However, that drug may be optimal therapy for one subgroup of SLE patients.

85. Arthritis Research Campaign | Systemic Lupus Erythematosus (SLE)
    systemic lupus erythematosus (SLE) is a chronic autoimmune disease which produces symptoms varying from very mild to lifethreatening.  
    http://www.arc.org.uk/about_arth/med_reports/series3/pp/6332/6332.htm
    
    Extractions: Selly Oak Hospitals, Birmingham Systemic lupus erythematosus (SLE) is a chronic autoimmune disease which produces symptoms varying from very mild to life-threatening. It characteristically affects young women but all ages can be affected. The most distinct immunological abnormality is the presence of autoantibodies, with anti-nuclear antibodies directed against native double-stranded DNA being diagnostic. The course of the disease is characterised by periods of remission and relapse. The skill of management is to predict and hence prevent flares of disease activity. A continued awareness of the possibility of the disease and the necessity of prompt referral for expert management are two important aspects of care. The prevalence of SLE is 4-280 cases per 100,000 (based on ARA criteria, Table 1), the highest prevalence being in Afro-Caribbeans, followed by Asians. The sex ratio is 13:1 in favour of females, which is reduced in both children (ratio 1.4:1) and the elderly in whom it is rarer and milder. Disease onset is usually between the ages of 16 and 55. Blacks have a worse prognosis associated with increased prevalence of renal disease and certain autoantibodies (anti-Sm, anti-RNP). The concordance rate for monozygotic twins is up to 50%, and 10% of relatives of patients with SLE may be affected. Multiple genes have been implicated (eg HLA B8, DR2, DR3 and complement deficiency genes). There are clear associations between certain genetic markers, autoantibodies and clinical disease.

86. Systemic Lupus Erythematosus
    systemic lupus erythematosus. Definition A chronic, inflammatory autoimmune disorder that may affect many organ systems including  
    http://www.healthscout.com/ency/article/000435.htm
    
    Extractions: Causes, incidence, and risk factors: Normally the immune system controls the body's defenses against infection. In systemic lupus erythematosus (SLE) and other autoimmune diseases , these defenses are turned against the body and rogue immune cells attack tissues. Antibodies may be produced that can react against the body's blood cells, organs, and tissues. These lead immune cells to attack the affected systems, producing chronic disease.

87. Immunity: TianGui And Systemic Lupus Erythematosus
    Immunity TianGui and systemic lupus erythematosus. Paolo Evangelista MD General Practitioner and Acupuncturist Italy email pevangel  
    http://users.med.auth.gr/~karanik/english/articles/lupus.html
    
    Extractions: http://www.geocities.com/HotSprings/Spa/4836/index.htm [Translated and edited by Phil Rogers MRCVS, March 1998] Summary and Conclusions The article has three parts: (a) a summary of some Chinese work on the effects of AP on the immune system; (b) a discussion of the influence of TianGui on immune function, in line with the Traditional Chinese Medical (TCM) theory of acupuncture (AP); and (c) the results of AP treatment of four cases of SLE. As proposed in the theory of TCM, TianGui seemed to activate the immune response. On applying TCM theory to four clinical cases of Systemic Lupus Erythematosus (SLE), AP was seemed to be an effective therapy for this difficult condition. This is a clinical study of a small number of cases. Because of its limited nature, it is not scientific proof of the efficacy of AP in SLE. However, it suggests that controlled studies of AP in SLE are desirable. Introduction Traditional Chinese Medicine (TCM) has held for over two millennia that the body has an innate system to defend against external and internal attack, and that the system can be activated by a many TCM procedures (balanced life-style, herbal medicine, AP, Taiqi, Qigong, Tuina etc).

88. Drugstore.com - Systemic Lupus Erythematosus
    systemic lupus erythematosus back to health guide all healthnotes indexes health concerns index. Checklist for systemic lupus erythematosus.  
    http://www.drugstore.com/templates/hnotes/default.asp?catid=40578

89. CHRYOUR HEALTH
    systemic lupus erythematosus, sensitivity to sunlight. Symptoms of systemic lupus erythematosus may include joint pain and swelling; fever;  
    http://www.calgaryhealthregion.ca/hlthconn/items/sle.htm
    
    Extractions: Systemic Lupus Erythematosus Lupus erythematosus is a 'chronic' disease meaning that the symptoms come and go over time. We now recognize lupus as an 'auto-immune' disease. This means that the immune system, which normally protects the body from germs, abnormal cells and foreign substances, does not work properly. In an auto-immune disease, the immune system identifies its own cells as being abnormal or foreign and sends antibodies to attack the body's normal cells. The result is inflammation and scarring of the tissues involved. In lupus, the immune system specifically attacks the connective tissue that surrounds various parts and organs of the body. It causes inflammation and damage to a wide variety of body tissues the skin, joints, blood cells, kidneys and lungs as well as other organs and tissues. There are two main types of lupus erythematosus: Symptoms of lupus erythematosus The symptoms of both DLE and SLE come and go over time. Symptoms can vary widely from person to person and may range from mild symptoms to severe. Initially, there are flu-like symptoms ( fatigue, fever, aching muscles and joints). The initial symptoms may last for several months. Over time more specific symptoms of lupus may begin to appear. Because SLE can target many parts of the body, there is often a wide variety of symptoms and SLE can be difficult to diagnose.

90. European Lupus Erythematosus Federation
    Lupus in internet Further informations about systemic lupus erythematosus and related topics in internet. MednetRheuma SLE - systemic lupus erythematosus.  
    http://www.elef.rheumanet.org/
    
    Extractions: Please send questions or comments to elef@rheumanet.org Converted to HTML by Team-RheumaNet So few have heard of it, yet worldwide it's seen as more common than leukaemia muscular dystrophy and multiple sclerosis. 90% of the patients who suffer from Lupus are female of childbearing age. Even young children can be affected by lupus. Lupus is a condition whereby the body's defence mechanism goes into overdrive and starts to attack itself. The symptoms are many and varied, and the illness often seems to mimic other diseases. This gives rise to difficulty in diagnosis and the condition can be overlooked, sometimes for years, unless the General Practioner or consultant is alert to the possibility of lupus. LUPUS IS NOT CONTAGIOUS Lupus can be triggered - at puberty - during the menopause - after childbirth - after viral infection - through sunlight - as a result of trauma - after a prolonged course of medication THE SYMPTOMS These may include - extreme fatigue - joint and muscle pain - eye problems - depression

91. Systemic Lupus Erythematosus: The Disease And Its Patients
    systemic lupus erythematosus The disease and its Patients. Jon Russell, MD, PHD, Health Science Center, University of Texas San Antonio, TX.  
    http://www.elef.rheumanet.org/newsletter/6/systemic.htm
    
    Extractions: Jon Russell, MD, PHD, Health Science Center, University of Texas San Antonio, TX A selection from the Lupus Foundation of America Newsletter Article Library "What is SLE?" Some of you have recently heard yourself ask that questions. I have WHAT? What is Lupus? Other of you have known of that diagnosis for many years, but still meet such questions in conversation with friends or acquaintances. Systemic Lupus Erythematosus (SLE) is a relatively uncommon autoimmune disorder in which the body=s immune forces are turned against ist own tissues and organs. The normal immune system is composed of several different forms of white blood cells which normally circulate in the bloodstream and take up residence in such organs as the spleen and lymph nodes. Their normal function is to recognize and destroy foreign invaders, such as bacteria, which are constantly attempting to gain access. A complex identification system exists which allows these cells to recognize the difference between the body=s normal cells, called self, from those foreign invaders, called non-self. Self-tissues are not normally attacked because they are recognized as belonging there. The problem in Lupus, we believe, is that the fail-safe mechanism, at times, is bypassed. The guardians of the body=s internal peace and safety, the white blood cells, get their identification signals confused and turn their destructive powers on the body=s own tissues because they see them as being foreign. It is as if the National Guard were to become confused in scattered parts of our country, and begin to attack our own citizens, as if they were all agents of the enemy.

92. InteliHealth: Lupus
    information. systemic lupus erythematosus (SLE) is most easily recognized by a occasional rash over the cheeks and bridge of the nose.  
    http://www.intelihealth.com/IH/ihtIH/WSIHW000/9071/8318/201966.html?d=dmtHealthA

93. IBMS Science: Systemic Lupus Erythematosus
    Science Immunology. systemic lupus erythematosus At a recent meeting of the Sussex Branch, Dr Sarah Deacock, the consultant immunologist  
    http://www.ibmsscience.org/immunology/sle.htm
    
    Extractions: www.careerscene.com Systemic Lupus Erythematosus At a recent meeting of the Sussex Branch, Dr Sarah Deacock, the consultant immunologist at the Royal Sussex County Hospital in Guildford, spoke about systemic lupus erythematosus (SLE). She said that this was a multisystem autoimmune illness which could affect any organ system and likened it to the many headed hydra due to the range of disease that could be encountered. Moreover as one symptom was dealt with others could emerge. A diagnosis of SLE was made if a patient fulfilled four or more of the eleven criteria shown in the table. The presenting clinical features depended on the organ systems affected by the disease. However generalised non-specific symptoms included fever, tiredness, anorexia, weight loss and lymphadenopathy. Patients tended to have an elevated erythrocyte sedimentation rate (ESR) in the presence of a normal result for C reactive protein (CRP). A high CRP result was associated with the presence of active infection. The muscular skeletal system may be affected with patients complaining of arthralgia and myalgia. The arthritis associated with SLE was typically non-erosive and reversible as seen in Jaccoud's arthropathy. Avascular necrosis of bone due to prolonged steroid treatment could result in severe damage to the hip joint. Osteoporosis resulted from avoidance of sunlight, steroid treatment and decreased exercise indicating that regular bone densitometry could assist in the management of these patients.

94. Trends In Deaths From Systemic Lupus Erythematosus --- United States, 1979--1998
    Trends in Deaths from systemic lupus erythematosus United States, 19791998. Mortality and causes of death in systemic lupus erythematosus.  
    http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5117a3.htm
    
    Extractions: Systemic lupus erythematosus (SLE) is a serious autoimmune disease of unknown etiology that can affect several organs. Because SLE affects connective tissues and because painful joints and arthritis are among its most common manifestations, this disease is classified with arthritis and other rheumatic diseases ( ). SLE is one of the more fatal forms of rheumatic diseases and non-Causcasian race is a risk factor for death from SLE; however, trends in death from SLE have not been analyzed recently. To characterize deaths from SLE, CDC reviewed SLE deaths during 19791998. This report presents the results of that analysis, which indicate that marked age-, sex-, and race-specific disparities exist in SLE death rates and that death rates have increased by approximately 70% during the study period among black women aged 4564 years. Prevention of deaths requires early recognition and diagnosis of SLE and appropriate therapeutic management. The analysis used National Center for Health Statistics Multiple Cause-of-Death Public Use Data Tapes for 19791998. These national mortality statistics were based on data from death certificates filed in state vital statistics offices. Demographic data (e.g., age and race/ethnicity) listed on death certificates were reported by funeral directors, usually from information provided by the decedent's family. Causes of death listed on death certificates were reported by a physician, medical examiner, or coroner by using a format specified by the World Health Organization and endorsed by CDC. An SLE death was defined as any death of a U.S. resident coded with an underlying cause of death of systemic lupus erythematosus (

95. MSRGSNet/Genetic Drift/Teratogen Update/Maternal Disorders
    See References Diabetes Mellitus. systemic lupus erythematosus and Antiphospholipid Antibodies. See References systemic lupus erythematosus.  
    http://www.mostgene.org/gd/gdvol12e.htm
    
    Extractions: Reviewed Jan, 2000 Phenylketonuria Phenylketonuria (PKU) is an autosomal recessive disorder of amino acid metabolism affecting approximately 1/10,000"-1"5,000 infants in North America. It is most often due to deficiency of the enzyme phenylalanine hydroxylase which causes the accumulation of harmful metabolites, including phenylketones. If untreated, PKU leads to mental retardation, seizures, psychoses, eczema and a distinctive "mousy" odor. A diet low in phenylalanine has been proven to prevent neurological and intellectual deterioration, if initiated in early infancy. Historically, this diet was discontinued at age 6 since it was felt the brain was fully developed by that time and would not be susceptible to the effects of excess phenylalanine and its derivatives. Currently, it is recommended that diet therapy be continued throughout an affected person's lifetime to prevent the decline in intellect that has been documented in some cases, as well as harm to fetuses of affected women.

96. Systemic Lupus Erythematosus (SLE) - Mesa Veterinary Hospital
    systemic lupus erythematosus (SLE) by Amy Skladzien, DVM.  
    http://www.mesavet.com/library/sle.htm
    
    Extractions: by Amy Skladzien, DVM SLE is an immune-mediated disease in which the immune system attacks the body's own organs. What causes this to happen is unknown, but certain breeds are thought to be affected more often. These include Shetland sheepdogs (Shelties), collies, Afghan hounds, and German shepherds. Symptoms can begin showing slowly, or very suddenly. Commonly, animals are brought in to the vet for lameness which is being caused by arthritis or muscle inflammation, but they may also be brought in for anorexia, weakness, fever, seizures, or swollen lymph nodes. In SLE antibodies attack the body's own cells and incite inflammation in tissues such as the kidney, joint capsule lining, and blood vessels. Renal failure, arthritis, and anemia are just a few of the complications of SLE. Diagnosing SLE can be difficult because there is not one specific test for it. There are two blood tests which, in conjunction with clinical signs can help support a diagnosis of SLE. Treatment is focused on decreasing the amount of inflammation in the affected tissues and treating any concurrent infections. This is generally done through using drugs which suppress the immune system and the appropriate antibiotics for any infections present. Success of treatment and prognosis for the pet depends of what stage the animal is in at the time of diagnosis, and whether there are any infections present. Once diagnosed, animals need to be treated aggressively to attempt to contro the disease.

97. Environmental Protection Agency: ORSEARTH
    Executive summary of the Investigation of systemic lupus erythematosus in Nogales, Arizona. An elevated prevalence of systemic lupus  
    http://www.epa.gov/orsearth/lupus5a.htm
    
    Extractions: US-Mexico Border 2012 Environmental Health Workgroup Recent Additions Contact Us Print Version Search: EPA Home US-Mexico Border 2012 EHWG Mission/Objectives ... Directory An elevated prevalence of systemic lupus erythematosus (SLE) was reported in 1996 in Nogales, Arizona and Rio Rico, a nearby community. In March 1997, the Arizona Department of Health (ADH) requested assistance from the Centers for Disease Control and Prevention (CDC) to conduct a case-control study to determine whether exposure to chemicals in the environment was associated with SLE among residents of Nogales. A two-phase study was conducted to address this question. The objectives of Phase I were to identify potential SLE cases in Nogales, determine the prevalence of SLE in Nogales and determine if there was a seasonal pattern to the appearance of SLE symptoms. The objectives of Phase II were to identify potential risk factors associated with development of SLE in Nogales and to evaluate the possible association between SLE and environmental exposure to pesticides and inorganic compounds. Data collection for the study started on November 1997 and ended July 1999.

98. MARRTC: SWRAC: Lupus Erythematosus
    systemic lupus erythematosus. By Anne Winkler, MD, PhD The most common symptoms of systemic lupus erythematosus include fever and fatigue.  
    http://www.muhealth.org/~arthritis/swrac/win00news/lupus.html
    
    Extractions: Conditions General Arthritis Rheumatoid Arthritis Osteoarthritis Juvenile Arthritis Fibromyalgia Missouri Calender Regional Cntrs JA Program Advisory Board MARRTC About Us Spotlight Publications Contact Us You are here: Home Articles SWRAC Win00 Newsltr Lupus By Anne Winkler, MD, PhD Systemic lupus erythematosus is a chronic systemic disease in which the immune system attacks the body in a very characteristic way. This disease is very common in young women, although it can also occur in infants as well as the elderly. The peak onset occurs between the ages of 15 and 40 or during the childbearing years. It has a female to male ratio of approximately 5:1. With better techniques for diagnosing and recognizing lupus, we now see approximately 1 out of every 2,000 individuals in the general population who have lupus. The pathophysiology of lupus, or why people develop lupus, is unclear. We do know that the immune system makes a variety of antibodies that then can deposit in different organs, including the skin, joints, and kidneys. This deposition then can cause damage in the organs that contain these antibodies. We can measure these antibodies in terms of both making the diagnosis of lupus and also use those antibody levels to help us monitor how effectively we are treating the patient. There are, however, some patients with lupus who have negative antibodies. Most patients with lupus have the antinuclear antibody, which is the screening test for lupus but can also be found in other connective tissue diseases. The most serious antibody is the DNA antibody, which is more commonly associated with kidney involvement.

99. Systemic Lupus Erythematosus (SLE, Or Lupus) - Lucile Packard Children's Hospita
    Pediatric Arthritis Other Rheumatic Diseases. systemic lupus erythematosus (SLE, or Lupus) What is lupus? systemic lupus erythematosus  
    http://www.lpch.org/DiseaseHealthInfo/HealthLibrary/arthritis/lupus.html
    
    Extractions: What is lupus? Systemic lupus erythematosus, also known as SLE, or simply lupus, is a disease that is characterized by periodic episodes of inflammation of and damage to the joints, tendons, other connective tissues, and organs, including the heart, lungs, blood vessels, brain, kidneys, and skin. The heart, lungs, kidneys, and brain are the organs most affected. Lupus affects each individual differently and the effects of the illness range from mild to severe. Lupus can potentially be fatal. The majority of people who have lupus are young women (late teens to 30s). This may be due to the fact that estrogen (a female hormone) seems to be associated with SLE. Lupus affects more African-Americans than Caucasians, Asian Americans, Latinos, or Native Americans in the US. Lupus in children occurs most often at the age of ten and older; lupus is rare in children younger than 5 years of age. The disease is known to have periods of flare-ups and periods of remission (partial or complete lack of symptoms). Children with lupus can have a large degree of kidney involvement. The severity of the kidney involvement can alter the survival rate of patients with lupus. In some cases, kidney damage is so severe it leads to kidney failure.

100. Systemic Lupus Erythematosus: Comprehensive Online Library Of Resources Dealing
     CTRL+D will bookmark this page! systemic lupus erythematosus Online. Click here for alphabetical listing. Great Offers. 1. Magazine Subscriptions.  
     http://www.autoimmune-disease.com/lupus_erythematosus.htm
     
     Extractions: CTRL D will bookmark this page! Click here for alphabetical listing Great Offers Magazine Subscriptions Office Supplies DVD Movies Music Clubs ... Add a Link Search: All Products Books Popular Music Classical Music Video Toys Consumer Electronics Home Improvement Keywords: Please Support Our Sponsors Useful Links Online Dictionaries A comprehensive collection of all kinds of online dictionaries: you can find any English dictionary, language dictionary, slang dictionary, medical and law dictionaries among many others on this site. Wow!!!

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

81-100 of 104    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20